Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-23-050892
Filing Date
2023-11-01
Accepted
2023-11-01 17:18:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 ny20009756x12_424b3.htm 424B3 272015
2 logo_catalystbio.jpg GRAPHIC 40022
3 logo_gyre.jpg GRAPHIC 26811
  Complete submission text file 0001140361-23-050892.txt   364865
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-273395 | Film No.: 231369217
SIC: 2834 Pharmaceutical Preparations